Your browser doesn't support javascript.
loading
Unravelling the role of long non-coding RNAs in modulating the Hedgehog pathway in cancer.
Chandel, Shailendra Singh; Mishra, Anurag; Dubey, Gaurav; Singh, Ravindra Pal; Singh, Mithilesh; Agarwal, Mohit; Chawra, Himmat Singh; Kukreti, Neelima.
Afiliação
  • Chandel SS; NIMS Institute of Pharmacy, NIMS University Rajasthan, Jaipur, India.
  • Mishra A; NIMS Institute of Pharmacy, NIMS University Rajasthan, Jaipur, India.
  • Dubey G; NIMS Institute of Pharmacy, NIMS University Rajasthan, Jaipur, India.
  • Singh RP; NIMS Institute of Pharmacy, NIMS University Rajasthan, Jaipur, India.
  • Singh M; NIMS Institute of Pharmacy, NIMS University Rajasthan, Jaipur, India.
  • Agarwal M; NIMS Institute of Pharmacy, NIMS University Rajasthan, Jaipur, India. Electronic address: mohit.agarwal@nimsuniversity.org.
  • Chawra HS; NIMS Institute of Pharmacy, NIMS University Rajasthan, Jaipur, India.
  • Kukreti N; School of Pharmacy, Graphic Era Hill University, Dehradun 248007, India.
Pathol Res Pract ; 254: 155156, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38309021
ABSTRACT
Cancer is a multifactorial pathological condition characterized by uncontrolled cellular proliferation, genomic instability, and evasion of regulatory mechanisms. It arises from the accumulation of genetic mutations confer selective growth advantages, leading to malignant transformation and tumor formation. The intricate interplay between LncRNAs and the Hedgehog pathway has emerged as a captivating frontier in cancer research. The Hedgehog pathway, known for its fundamental roles in embryonic development and tissue homeostasis, is frequently dysregulated in various cancers, contributing to aberrant cellular proliferation, survival, and differentiation. The Hh pathway is crucial in organizing growth and maturation processes in multicellular organisms. It plays a pivotal role in the initiation of tumors as well as in conferring resistance to conventional therapeutic approaches. The crosstalk among the Hh pathway and lncRNAs affects the expression of Hh signaling components through various transcriptional and post-transcriptional processes. Numerous pathogenic processes, including both non-malignant and malignant illnesses, have been identified to be induced by this interaction. The dysregulation of lncRNAs has been associated with the activation or inhibition of the Hh pathway, making it a potential therapeutic target against tumorigenesis. Insights into the functional significance of LncRNAs in Hedgehog pathway modulation provide promising avenues for diagnostic and therapeutic interventions. The dysregulation of LncRNAs in various cancer types underscores their potential as biomarkers for early detection and prognostication. Additionally, targeting LncRNAs associated with the Hedgehog pathway presents an innovative strategy for developing precision therapeutics to restore pathway homeostasis and impede cancer progression. This review aims to elucidate the complex regulatory network orchestrated by LncRNAs, unravelling their pivotal roles in modulating the Hedgehog pathway and influencing cancer progression.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Longo não Codificante / Neoplasias Tipo de estudo: Screening_studies Limite: Humans Idioma: En Revista: Pathol Res Pract Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Longo não Codificante / Neoplasias Tipo de estudo: Screening_studies Limite: Humans Idioma: En Revista: Pathol Res Pract Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia